 This statistic shows AstraZeneca's research & development expenditure as a percentage of its total revenue from 2006 to 2018. In 2018, the company invested over 28 percent of its revenue into research and development. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. 